Revisions to Cutaneous Adverse Event Classification in CTCAE Version 6.0

Journal of the American Academy of Dermatology · Published 2026-08-01 · DOI 10.1016/j.jaad.2026.07.101

Free full text

Authors (4)

David Bomze, Nadav Astman, Ilan Goldberg, Tomer Goldsmith

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Bomze, D., Astman, N., Goldberg, I., et al. (2026). Revisions to Cutaneous Adverse Event Classification in CTCAE Version 6.0. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.07.101

Related articles

• 73223 Developing and Testing the Effectiveness of a Skin Cancer Self-Detection Educational Program: A Randomized Controlled Trial · Journal of the American Academy of Dermatology · 2026 · Same journal
• 73890 Cost-Conscious Care Strategies for Dermatology · Journal of the American Academy of Dermatology · 2026 · Same journal
• Comparative effectiveness of dupilumab and JAK inhibitors in atopic dermatitis: Dose reduction compromises efficacy of JAK inhibitors—The CORNERSTONE study · Journal of the American Academy of Dermatology · 2026 · Same journal
• 72313 Impact of Microneedling Characteristics and Drug Properties on the Efficacy of Microneedling-Assisted Drug Delivery: A Systematic Review and Meta-Analysis with Biochemical, Histologic, and Ultrastructural Imaging Correlation · Journal of the American Academy of Dermatology · 2026 · Same journal
• 77577 Diagnostic Challenges in Pediatric Hidradenitis Suppurativa: Hidden in Plain Sight · Journal of the American Academy of Dermatology · 2026 · Same journal
• 76457 Assessment of Large Language Model-Generated Dermatology Images: Accuracy, Realism, and Educational Utility · Journal of the American Academy of Dermatology · 2026 · Same journal
• 76056 Prospective, Double-Blind, Vehicle Controlled Assessment of Topical Bakuchiol on Photoaging in a Chinese Population · Journal of the American Academy of Dermatology · 2026 · Same journal
• A 48-week real-world effectiveness of nemolizumab for pediatric patients with atopic dermatitis · Journal of the American Academy of Dermatology · 2026 · Same journal
• 74363 Differences in Skin Cancer Presentation by Race: A County Hospital Retrospective Analysis · Journal of the American Academy of Dermatology · 2026 · Same journal
• 77194 Sentinel Lymph Node Biopsy Does Not Improve Prognostic Stratification in Thin Melanoma: A Competing-Risks Analysis · Journal of the American Academy of Dermatology · 2026 · Same journal